Literature DB >> 2914915

Phorbol esters stimulate phosphorylation of eukaryotic initiation factors 3, 4B, and 4F.

S J Morley1, J A Traugh.   

Abstract

Eukaryotic initiation factor (eIF) 4F, a multiprotein cap binding complex, was isolated by m7 GTP-Sepharose affinity chromatography from rabbit reticulocytes incubated with [32P]orthophosphate. Following treatment of reticulocytes with phorbol 12-myristate 13-acetate (PMA) for 30 min, stimulation of phosphorylation of both the p25 and p220 subunits was observed (2.5-5-fold). Two variants were observed for p25 in the absence and presence of PMA when analyzed by two-dimensional gel electrophoresis. Only the more acidic of these was phosphorylated, with the level of phosphorylation increased upon PMA treatment. One main variant was observed for p220; following PMA stimulation, in addition to increased labeling of this variant, two more acidic phosphorylated variants were observed. Low levels of eIF-3 and -4B were associated with purified eIF-4F, and PMA treatment stimulated phosphorylation of eIF-3 (p170) by 2-4-fold and eIF-4B by 1.5-2.5 fold. Two-dimensional phosphopeptide mapping of p25 phosphorylated in the absence or presence of PMA generated a single tryptic phosphopeptide, suggesting a single phosphorylation site. A more complex phosphopeptide map was observed with p220 subunit. The maps for both subunits contained the same phosphopeptides as those obtained when eIF-4F was phosphorylated in vitro by the Ca2+/phospholipid-dependent protein kinase, indicating this protein kinase directly modulated eIF-4F in response to PMA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  Serum-stimulated, rapamycin-sensitive phosphorylation sites in the eukaryotic translation initiation factor 4GI.

Authors:  B Raught; A C Gingras; S P Gygi; H Imataka; S Morino; A Gradi; R Aebersold; N Sonenberg
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

Review 3.  Mechanism and regulation of eukaryotic protein synthesis.

Authors:  W C Merrick
Journal:  Microbiol Rev       Date:  1992-06

Review 4.  Regulation of protein turnover in skeletal and cardiac muscle.

Authors:  P H Sugden; S J Fuller
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

5.  DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death.

Authors:  N Levy-Strumpf; L P Deiss; H Berissi; A Kimchi
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

6.  Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation.

Authors:  D Feigenblum; R J Schneider
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F.

Authors:  A De Benedetti; S Joshi-Barve; C Rinker-Schaeffer; R E Rhoads
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

8.  Modification of eukaryotic initiation factor 4F during infection by influenza virus.

Authors:  D Feigenblum; R J Schneider
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

9.  Translational regulation during activation of porcine peripheral blood lymphocytes: association and phosphorylation of the alpha and gamma subunits of the initiation factor complex eIF-4F.

Authors:  S J Morley; V M Pain
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.

Authors:  S Pyronnet; H Imataka; A C Gingras; R Fukunaga; T Hunter; N Sonenberg
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.